Lifesaving medicine for diabetics that costs up to €130 is not yet on the national formularly despite multiple appeals by healthcare professionals, MEP Francis Zammit Dimech has noted.
Dr Zammit Dimech, who co-chairs the EU diabetes working group, urged the government to follow in the footsteps of other EU member states, such as the UK, in making GLP-1 Agonists and SGLT2 inhibitors available to public healthcare patients, and not just privately.
Dr Zammit Dimech, who is contesting this month’s MEP elections, also said that many families with diabetic children were still waiting to receive continuous blood glucose monitors, despite government promises to make these available.
CGM can help kids to monitor their sugar level without needing to prick their fingers several times a day.
Read: Diabetics should get free needles, says Zammit Dimech